•  
  •  
  •  
  •  

2026-07-24 17:44:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Shriram Finance Delivers Strong Q1 FY27 Results: Consolidated Net Profit Surges 60% YoY to ₹3,453 Crore; AUM Reaches ₹3.14 Lakh Crore
  • ZF Commercial Vehicle Control Systems India Reports Q1 FY27 Revenue Up 9% YoY to ₹1,066 Crore; Net Profit Stands at ₹104.5 Crore
  • Ponni Sugars (Erode) Reports Q1 FY27 Results: Operational Turnaround Reduces Net Losses to ₹1.23 Crore as Revenue Surges 52% YoY
  • Dolphin Offshore Enterprises Reports 31% Rise in Q1 FY27 Net Profit to ₹14.81 Crore; Revenue Surges 161% YoY to ₹42.85 Crore
  • Dr. Lal PathLabs Reports Strong Q1 FY27 Performance with Net Profit Rising 27% YoY to ₹1,705 Million; Revenue Up 19%

Keywords Selected:  Trials

Research

  • Industrials - Q2FY22 Results Preview - Strong execution pick-up - HDFC Securities

Stock Report

  • Zydus receives approval from DCGI to initiate Phase III trials of Zintrodiazine, a novel anti-malarial candidate
  • Apollo Micro Systems Ltd - Business Update
  • Time Technoplast Ltd announces successful completion of trials for Hydrogen Powered Drones with Type III Composite Hydrogen Cylinder & Hydrogen Fuel Cells
  • Geomysore commences pre commercial production trials at Jonnagiri Process Plant
  • Pasupati Acrylon Limited updates on Ethanol Project
  • Kesar Petroproducts Limited commences trials at new fertilizers unit
  • Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20%
  • Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease
  • Basin Trials of the Missile Destroyer at Mazagon Dock Shipbuilders Ltd
  • Airtel, Apollo Hospitals, AWS carry out India's first 5G driven, Artificial Intelligence guided Colonoscopy trial
  • TCS ADD™ Connected Clinical Trials Wins the India Pharma Award 2022
  • Dai-ichi Karkaria Ltd to start trial production at new plant
  • Panafic Industrials Ltd board approves rights issue
  • TCS Launches Risk-Based Monitoring Solution that Transforms Clinical Operational Analytics and Enhances Study Quality
  • Coromandel International conducts Drone Trials in Hyderabad
  • Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting

Latest Post

  • Shriram Finance Delivers Strong Q1 FY27 Results: Consolidated Net Profit Surges 60% YoY to ₹3,453 Crore; AUM Reaches ₹3.14 Lakh Crore
  • ZF Commercial Vehicle Control Systems India Reports Q1 FY27 Revenue Up 9% YoY to ₹1,066 Crore; Net Profit Stands at ₹104.5 Crore
  • Ponni Sugars (Erode) Reports Q1 FY27 Results: Operational Turnaround Reduces Net Losses to ₹1.23 Crore as Revenue Surges 52% YoY
  • Dolphin Offshore Enterprises Reports 31% Rise in Q1 FY27 Net Profit to ₹14.81 Crore; Revenue Surges 161% YoY to ₹42.85 Crore
  • Dr. Lal PathLabs Reports Strong Q1 FY27 Performance with Net Profit Rising 27% YoY to ₹1,705 Million; Revenue Up 19%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025